Table 1. Pain and erythema scores, and dermal thickness in patients
with ALDS prior to and after the 8-week treatment with stanozolol.
|
|
Patients (n=17) |
Minimal value |
Maximal value |
Mean |
SD |
Z value |
P value |
|
Pain score |
Prior to tx |
4 |
10 |
6.76 |
1.99 |
3.70 |
<0.001 |
|
End of tx |
0 |
5 |
3.12 |
1.62 |
|||
|
Erythema score |
Prior to tx |
2 |
3 |
2.76 |
0.43 |
3.82 |
<0.001 |
|
End of tx |
0 |
2 |
0.76 |
0.56 |
|||
|
|
t value |
P value |
|||||
|
Dermal thickness (mm) |
Prior to tx |
2.15 |
3.50 |
2.64 |
0.44 |
16.782 |
<0.001 |
|
End of tx |
1.50 |
3.20 |
2.15 |
0.52 |
|||
ALDS, acute lipodermatosclerosis; tx, treatment with stanozolol